A cap and seal system for a liquid medicament container. The system comprises a cap formed from a substantially rigid material and has a retention component integrally formed therewith. A seal is formed from a material which is less hard than the cap and positioned within the cap such that, when the retaining component retains the cap on a container in use the seal is positioned such that it forms a fluid tight seal between the cap and the container. A recess is formed in the seal through which a liquid outlet channel can pass in use to access the contents of the container via the cap and the seal.

A port includes a conduit configured to receive a spike therein. The conduit includes a first portion, a second portion, and a septum fluidly separates the first portion and the second portion of the conduit. The septum is puncturable by the spike so as to allow the spike to be inserted into the second portion of the conduit. A removable snap portion extends from a break point to the tip of the port. The thickness of the break point is less than the thickness of the remainder of the conduit wall. The removable snap portion is configured to break away from the port at the break point such that the septum is accessible by the spike via the first portion of the conduit when the removable snap portion is broken away from the port. The port may include fluorinated ethylene propylene, ethylene tetrafluoroethylene, perfluoroalkoxy alkane, and combinations thereof.

A sealed pharmaceutical container comprises a shoulder, a neck extending from the shoulder, and a flange extending from the neck. The flange comprises an outer surface extending from the underside surface and a contact surface extending between the outer surface and an inner surface defining an opening in the sealed pharmaceutical container. The contact surface comprises an outer peripheral edge disposed proximate to the outer surface of the flange. The sealed pharmaceutical container comprises a sealing assembly comprising a stopper extending over the contact surface of the flange and covering the opening, and a cap securing the stopper to the flange. The stopper comprises a sealing surface that is secured in contact with the contact surface of the flange to form a seal between the flange and the stopper. An outer peripheral edge of the sealing surface is disposed at or radially inward of the outer peripheral edge.

A sealed pharmaceutical container comprises a flange comprising an underside surface, an outer surface extending from the underside surface, the outer surface defining an outer radius r.sub.o of the flange; and an upper surface extending between the outer surface and an inner surface defining an opening in the sealed pharmaceutical container. The upper surface comprises a sealing region extending between the opening and the outer surface and comprising a radius r.sub.sr that is less than r.sub.o. The sealed pharmaceutical container also comprises a sealing assembly comprising sealing portion in contact with the upper surface at a lower surface of the sealing portion and a cap compressing the stopper against the upper surface. After compression, the sealing portion of the stopper comprises a compressed radius r.sub.sc that is less than r.sub.sr adjacent the upper surface.

A receptacle is designed for a chamber for an active substance. The receptacle includes two main elements. A first element is a transverse wall with a first main side facing an interior of the chamber, and a peripheral wall formed with the first main side of the transverse wall. A second element includes a bottom wall and a sheath extending from the bottom wall. The peripheral wall and the sheath surround one another and are in contact with each other so that the chamber is formed between the bottom wall, the transverse wall, the peripheral wall and/or the sheath. At least one ventilation groove is provided between the peripheral wall and the sheath form a ventilation channel connecting the chamber with the outside atmosphere.

The invention pertains to a container for storing medical and/or pharmaceutical products. The container includes a plastic container body including a side wall, a base and an opening defining the storage volume, an active insert, placed inside the container body and including a tubular side wall of length L, extending from a lower extremity to an upper extremity, and an empty interstice between the side wall of the active insert and the side wall of the container body. This container is an improved container for the storage of medical and/or pharmaceutical products.

A top for a plasma storage container includes a top body that defines the structure of the top and seals an opening of the plasma storage container. The top also includes a first opening and a vent opening extending through the top body. A valve mechanism is located at least partially within the top body and includes an aperture therethrough. The aperture opens upon connection of a blunt cannula to provide access to the interior of the plasma storage container. The top also includes a vent filter. The vent filter allows air to vent through the vent opening during plasma collection.

Disclosed is a container stopper (100) coupled to a container inlet (12) of a container (10) in which content is held, the container stopper comprising: a stopper body (110) that is coupled to the container inlet (12) and has, on the upper side thereof, an auxiliary space (S1) in which auxiliary content (42) having a granular structure is held; and an upper cover (120) that is coupled to the stopper body (110), forms the auxiliary space (S1) together with the stopper body (110), and covers the auxiliary space (S1).

A closure for a pharmaceutical vial. The closure comprises an aluminum foil with an inductively meltable adhesive, an elastic seal, and a cap. The cap has an opening through which a perforating cannula can be inserted.

A system for dispensing a prescription medication in a controlled manner is disclosed. The system may include a prescription vial and a corresponding programmable cap. The cap may include an outer cover having an exit aperture, an inner cover having an entrance aperture, and a transport portion having a chute. The cap may also include a control system having a processor. In accordance with a schedule prescribed by a medical professional and programmed into the control system, the control system may dispense medication by moving the chute of the transport portion out of alignment with the entrance aperture and into alignment with the exit aperture.